Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Reshma Punjani, Theodore C. Larson, Laurie Wagner, Bryn Davis, D. Kevin Horton & Wendy Kaye. (2023) Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009–2011 and survival through 2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 203-211.
Read now
Read now
Elisa Bianchi, Elisabetta Pupillo, Antonio De Feudis, Gabriele Enia, Eugenio Vitelli & Ettore Beghi. (2022) Trends in survival of ALS from a population-based registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 344-352.
Read now
Read now
Florence Esselin, Elisa De La Cruz, Nicolas Pageot, Raul Juntas-Moralès, Sébastien Alphandéry & William Camu. (2021) Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 505-507.
Read now
Read now
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Read now
Hiroshi Mitsumoto, Diana C. Garofalo, Regina M. Santella, Eric J. Sorenson, Björn Oskarsson, J americo M. Fernandes$suffix/text()$suffix/text(), Howard Andrews, Jonathan Hupf, Madison Gilmore, Daragh Heitzman, Richard S. Bedlack, Jonathan S. Katz, Richard J. Barohn, Edward J. Kasarskis, Catherine lomen-Hoerth, Tahseen Mozaffar, Sharon P. Nations, Andrea J. Swenson & Pam Factor-Litvak. (2020) Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 263-272.
Read now
Read now
Débora Lanznaster, Theodora Bejan-Angoulvant, Franck Patin, Christian R. Andres, Patrick Vourc’h, Phillipe Corcia & HÉlÉne Blasco. (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 199-206.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
. (2018) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 198-216.
Read now
Read now
Susana Pinto & Mamede de Carvalho. (2017) Comparison of slow and forced vital capacities on ability to predict survival in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 528-533.
Read now
Read now
Christian Lunetta, Andrea Lizio, Mario Giovanni Melazzini, Eleonora Maestri & Valeria A. Sansone. (2016) Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 93-100.
Read now
Read now
Muhammad K. Rafiq, Michael Bradburn, Alison R. Proctor, Catherine G. Billings, Stephen Bianchi, Christopher J. McDermott & Pamela J. Shaw. (2015) A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 448-455.
Read now
Read now
Noa Keren, Kirsten M. Scott, Miho Tsuda, Jessica Barnwell, Jonathan A. Knibb, Cathy M. Ellis, P. Nigel Leigh, Christopher E. Shaw & Ammar Al-Chalabi. (2014) Evidence of an environmental effect on survival in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:7-8, pages 528-533.
Read now
Read now
. (2014) SESSION 1 JOINT OPENING SESSION. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:sup1, pages 1-56.
Read now
Read now
Michael E. Bozik, Hiroshi Mitsumoto, Benjamin R. Brooks, Stacy A. Rudnicki, Dan H. Moore, Bing Zhang, Albert Ludolph, Merit E. Cudkowicz, Leonard H. van den Berg, James Mather, Thomas Petzinger$suffix/text()$suffix/text() & Donald Archibald. (2014) A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 406-413.
Read now
Read now
Jeremy M. Shefner & Dragos Mihaila. (2014) Assessment of disease progression and functional benefit in neurodegenerative disease: Can we tell the difference?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 337-343.
Read now
Read now
Kay A. Lawton, Meredith V. Brown, Danny Alexander, Zhen Li, Jacob E. Wulff, Robert Lawson, Matt Jaffa, Mike V. Milburn, John A. Ryals, Robert Bowser, Merit E. Cudkowicz & James D. Berry. (2014) Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 362-370.
Read now
Read now
Tomi Aridegbe, Rosalind Kandler, Stephen J. Walters, Theresa Walsh, Pamela J. Shaw & Christopher J. McDermott. (2013) The natural history of motor neuron disease: Assessing the impact of specialist care. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:1, pages 13-19.
Read now
Read now
. (2012) PLATFORM COMMUNICATIONS. Amyotrophic Lateral Sclerosis 13:sup1, pages 1-58.
Read now
Read now
Sébastien Montel, Laurence Albertini, Claude Desnuelle & Elisabeth Spitz. (2012) The impact of active coping strategies on survival in ALS: The first pilot study. Amyotrophic Lateral Sclerosis 13:6, pages 599-601.
Read now
Read now
Mary R. O’Brien, Bridget Whitehead, Barbara A. Jack & J. Douglas Mitchell. (2012) The need for support services for family carers of people with motor neurone disease (MND): views of current and former family caregivers a qualitative study. Disability and Rehabilitation 34:3, pages 247-256.
Read now
Read now
Adriano Chiò, Giancarlo Logroscino, Orla Hardiman, Robert Swingler, Douglas Mitchell, Ettore Beghi, Bryan G. Traynor & On Behalf of the Eurals Consortium. (2009) Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis 10:5-6, pages 310-323.
Read now
Read now
Articles from other publishers (54)
Noah D. Gold, Austin J. MallardJacob C. HermannRichard J. ZeifmanBroc A. PagniMichael P. BogenschutzStephen Ross. (2023) Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis. Journal of Palliative Medicine.
Crossref
Crossref
Qi-Jie Zhang, Jian-Chai Huang, Jia Chen, Wei Hu, Liu-Qing Xu & Qi-Fu Guo. (2022) Peak expiratory flow is a reliably household pulmonary function parameter correlates with disease severity and survival of patients with amyotrophic lateral sclerosis. BMC Neurology 22:1.
Crossref
Crossref
Nora Hertel, Magdalena Kuzma-Kozakiewicz, Marta Gromicho, Julian Grosskreutz, Mamede de Carvalho, Hilmi Uysal, Reinhard Dengler, Susanne Petri & Sonja Körner. (2022) Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study. Frontiers in Neurology 13.
Crossref
Crossref
Wenbin Li, Qianqian Wei, Yanbing Hou, Du Lei, Yuan Ai, Kun Qin, Jing Yang, Graham J. Kemp, Huifang Shang & Qiyong Gong. (2021) Disruption of the white matter structural network and its correlation with baseline progression rate in patients with sporadic amyotrophic lateral sclerosis. Translational Neurodegeneration 10:1.
Crossref
Crossref
Aliona Cucovici, Andrea Fontana, Andrei Ivashynka, Sergio Russo, Valentina Renna, Letizia Mazzini, Ileana Gagliardi, Jessica Mandrioli, Ilaria Martinelli, Vitalie Lisnic, Dafin Fior Muresanu, Michele Zarrelli, Massimiliano Copetti & Maurizio A. Leone. (2021) The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Amyotrophic Lateral Sclerosis Progression: A Cross-Sectional Study. Life 11:4, pages 352.
Crossref
Crossref
Giulia Michela Pellegrino, Giuseppe Francesco Sferrazza Papa, Stefano Centanni, Massimo Corbo, David Kvarnberg, Martin J. Tobin & Franco Laghi. (2021) Measuring vital capacity in amyotrophic lateral sclerosis: Effects of interfaces and reproducibility. Respiratory Medicine 176, pages 106277.
Crossref
Crossref
Beatriz Grisolia Araujo, Luiz Felipe Souza e Silva, Jorge Luiz de Barros Torresi, Amanda Siena, Berenice Cataldo Oliveira Valerio, Mariana Dutra Brito & Tatiana Rosado Rosenstock. (2020) Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research. Molecular Neurobiology 57:12, pages 5084-5102.
Crossref
Crossref
Krzysztof Barć, Katarzyna Szacka, Krzysztof Nieporęcki, Mamede de Carvalho, Marta Gromicho, Julian Grosskreutz, Susanne Petri, Annekathrin Rödiger, Robert Steinbach, Hilmi Uysal & Magdalena Kuźma-Kozakiewicz. (2020) Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis. Aging and disease 11:5, pages 1021.
Crossref
Crossref
Mariana Dutra Brito, Gustavo Ferro Gomes da Silva, Erick Mutti Tilieri, Beatriz Grisolia Araujo, Michele Longoni Calió & Tatiana Rosado Rosenstock. (2019) Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review. Frontiers in Neurology 10.
Crossref
Crossref
Susana Pinto & Mamede de Carvalho. (2019) SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS. Frontiers in Neurology 10.
Crossref
Crossref
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Crossref
Mona Ahmadi, Elmira Agah, Shahriar Nafissi, Mahmoud Reza Jaafari, Mohammad Hossein Harirchian, Payam Sarraf, Sara Faghihi-Kashani, Seyed Jalal Hosseini, Abdolreza Ghoreishi, Vajiheh Aghamollaii, Mostafa Hosseini & Abbas Tafakhori. (2018) Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial. Neurotherapeutics 15:2, pages 430-438.
Crossref
Crossref
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink & Leonard H van den Berg. (2018) Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 89:2, pages 156-161.
Crossref
Crossref
Osamu Kano, Kazunori Tanaka, Takuya Kanno, Yasuo Iwasaki & Joh-E Ikeda. (2018) Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms. Scientific Reports 8:1.
Crossref
Crossref
Hiroshi MitsumotoToyokazu Saito. (2018) A prognostic biomarker in amyotrophic lateral sclerosis筋萎縮性側索硬化症の進行を示すバイオマーカー. Rinsho Shinkeigaku 58:12, pages 729-736.
Crossref
Crossref
Ludo Van Hillegondsberg, Jonathan Carr, Naeem Brey & Franclo Henning. (2017) Using Eulerian video magnification to enhance detection of fasciculations in people with amyotrophic lateral sclerosis. Muscle & Nerve 56:6, pages 1063-1067.
Crossref
Crossref
Fang Fang, Tracy L Peters, John D Beard, David M Umbach, Jean Keller, Daniela Mariosa, Kelli D Allen, Weimin Ye, Dale P Sandler, Silke Schmidt & Freya Kamel. (2017) Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis. American Journal of Epidemiology 186:9, pages 1057-1064.
Crossref
Crossref
Yukiko Tsuji, Yu-ichi Noto, Kensuke Shiga, Satoshi Teramukai, Masanori Nakagawa & Toshiki Mizuno. (2017) A muscle ultrasound score in the diagnosis of amyotrophic lateral sclerosis. Clinical Neurophysiology 128:6, pages 1069-1074.
Crossref
Crossref
Susan S Thomason. (2017) Clinical utility of riluzole in patients with motor neurone disease (amytrophic lateral sclerosis). British Journal of Neuroscience Nursing 13:2, pages 63-69.
Crossref
Crossref
Muhammad K Rafiq, Michael Bradburn, Naveed Mustfa, Christopher J McDermott & Djillali Annane. (2016) Mechanical cough augmentation techniques in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Emma Yates & Muhammad K. Rafiq. (2016) Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial. Journal of Clinical Neuroscience 32, pages 51-56.
Crossref
Crossref
M. K. Rafiq, E. Lee, M. Bradburn, C. J. McDermott & P. J. Shaw. (2016) Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. European Journal of Neurology 23:6, pages 1071-1078.
Crossref
Crossref
Junfang Wu, Anna Wuolikainen, Miles Trupp, Pär Jonsson, Stefan L. Marklund, Peter M. Andersen, Lars Forsgren & Anders Öhman. (2016) NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects. Metabolomics 12:6.
Crossref
Crossref
Valérie Cordesse, Florence Sidorok, Priscilla Schimmel, Josiane Holstein & Vincent Meininger. (2015) Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: a cohort study. BMC Health Services Research 15:1.
Crossref
Crossref
F. Patin, P. Corcia, B. Madji Hounoum, C. Veyrat‐Durebex, E. Respaud, E. Piver, I. Benz‐de Bretagne, P. Vourc'h, C. R. Andres & H. Blasco. (2015) Biological follow‐up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. European Journal of Neurology 22:10, pages 1385-1390.
Crossref
Crossref
Marwa Elamin, Peter Bede, Anna Montuschi, Niall Pender, Adriano Chio & Orla Hardiman. (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. Journal of Neurology 262:6, pages 1447-1454.
Crossref
Crossref
Seward B. Rutkove. (2015) Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 384-393.
Crossref
Crossref
J. D. Beard & F. Kamel. (2014) Military Service, Deployments, and Exposures in Relation to Amyotrophic Lateral Sclerosis Etiology and Survival. Epidemiologic Reviews 37:1, pages 55-70.
Crossref
Crossref
Nazem AtassiJames BerryAmy ShuiNeta ZachAlexander ShermanErvin SinaniJason WalkerIgor KatsovskiyDavid SchoenfeldMerit CudkowiczMelanie Leitner. (2014) The PRO-ACT database. Neurology 83:19, pages 1719-1725.
Crossref
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Crossref
Xueping Chen, Xiaoyan Guo, Rui Huang, Zhenzhen Zheng, Yongping Chen & Hui-fang Shang. (2014) An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis. Neurological Sciences 35:10, pages 1591-1597.
Crossref
Crossref
Philippe Couratier, Benoît Marin, Géraldine Lautrette, Marie Nicol & Pierre-Marie Preux. (2014) Épidémiologie, spectre clinique de la SLA et diagnostics différentiels. La Presse Médicale 43:5, pages 538-548.
Crossref
Crossref
Charlotte Veyrat-Durebex, Philippe Corcia, Aleksandra Mucha, Simon Benzimra, Cindy Mallet, Chantal Gendrot, Caroline Moreau, David Devos, Eric Piver, Jean-Christophe Pagès, François Maillot, Christian R. Andres, Patrick Vourc’h & Hélène Blasco. (2014) Iron Metabolism Disturbance in a French Cohort of ALS Patients. BioMed Research International 2014, pages 1-6.
Crossref
Crossref
Marie-Jo Thiel. 2014. Advance Directives. Advance Directives
17
35
.
James Rooney, Susan Byrne, Mark Heverin, Bernie Corr, Marwa Elamin, Anthony Staines, Ben Goldacre & Orla Hardiman. (2013) Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010. PLoS ONE 8:9, pages e74733.
Crossref
Crossref
Paul H. Gordon, François Salachas, Lucette Lacomblez, Nadine Le Forestier, Pierre-François Pradat, Gaelle Bruneteau, Alexis Elbaz & Vincent Meininger. (2013) Predicting Survival of Patients with Amyotrophic Lateral Sclerosis at Presentation: A 15-Year Experience. Neurodegenerative Diseases 12:2, pages 81-90.
Crossref
Crossref
Chris J Gibbons & Carolyn A Young. (2012) Assessing and managing depression and fatigue in motor neuron disease. Neurodegenerative Disease Management 2:4, pages 401-409.
Crossref
Crossref
Ken Ikeda, Takehisa Hirayama, Takanori Takazawa, Kiyokazu Kawabe & Yasuo Iwasaki. (2012) Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study. Internal Medicine 51:12, pages 1501-1508.
Crossref
Crossref
Paul H. Gordon & Vincent Meininger. (2011) How can we improve clinical trials in amyotrophic lateral sclerosis?. Nature Reviews Neurology 7:11, pages 650-654.
Crossref
Crossref
M. ElaminJ. PhukanP. BedeN. JordanS. ByrneN. PenderO. Hardiman. (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:14, pages 1263-1269.
Crossref
Crossref
P. Delguste. (2010) La sclérose latérale amyotrophique (SLA) — Quelques aspects éthiques liés à sa prise en charge pluridisciplinaireAmyotrophic lateral sclerosis (ALS)—Some ethical aspects linked to its multidisciplinary treatment. Réanimation 20:S2, pages 507-509.
Crossref
Crossref
Alvaro Alonso, Giancarlo Logroscino, Susan S Jick & Miguel A Hernán. (2010) Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurology 10:1.
Crossref
Crossref
Luc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, Philippe Jullien, Lucette Lacomblez, François Salachas, Gaëlle Bruneteau, Pierre-François Pradat, Jean-Philippe Loeffler & Vincent Meininger. (2010) Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 5:10, pages e13346.
Crossref
Crossref
Vincent Meininger. 2010. Traité de bioéthique. Traité de bioéthique
301
314
.
Takanori Takazawa, Ken Ikeda, Takehisa Hirayama, Kiyokazu Kawabe, Yoshikazu Nakamura, Hirono Ito, Osamu Kano, Yasuhiro Yoshii, Fumiaki Tanaka, Gen Sobue & Yasuo Iwasaki. (2010) Familial Amyotrophic Lateral Sclerosis with a Novel G85S Mutation of Superoxide Dismutase 1 Gene: Clinical Features of Lower Motor Neuron Disease. Internal Medicine 49:2, pages 183-186.
Crossref
Crossref
Ken Ikeda, Kiyokazu Kawabe & Yasuo Iwasaki. (2009) Do serum uric acid levels reflect oxidative stress in the progression of ALS?. Journal of the Neurological Sciences 287:1-2, pages 294.
Crossref
Crossref
Pierre-François Pradat & Michel Dib. (2012) Biomarkers in Amyotrophic Lateral Sclerosis. Molecular Diagnosis & Therapy 13:2, pages 115-125.
Crossref
Crossref
Femke Nijboer & Ursula Broermann. 2010. Brain-Computer Interfaces. Brain-Computer Interfaces
185
201
.
Freya Kamel, David M. Umbach, Lillian Stallone, Marie Richards, Howard Hu & Dale P. Sandler. (2008) Association of Lead Exposure with Survival in Amyotrophic Lateral Sclerosis. Environmental Health Perspectives 116:7, pages 943-947.
Crossref
Crossref
Eva Maria Hammer, Sonja Häcker, Martin Hautzinger, Thomas D. Meyer & Andrea Kübler. (2008) Validity of the ALS-Depression-Inventory (ADI-12)— A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. Journal of Affective Disorders 109:1-2, pages 213-219.
Crossref
Crossref
S. Zoccolella, E. Beghi, G. Palagano, A. Fraddosio, V. Guerra, V. Samarelli, V. Lepore, I. L. Simone, P. Lamberti, L. Serlenga & G. Logroscino. (2007) Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. European Journal of Neurology 14:3, pages 262-268.
Crossref
Crossref
Eric J. SorensonJayawant MandrekarBrian CrumJ. Clarke Stevens. (2007) Effect of referral bias on assessing survival in ALS. Neurology 68:8, pages 600-602.
Crossref
Crossref
P.Nigel Leigh. 2007. Motor neuron disorders and related diseases. Motor neuron disorders and related diseases
249
278
.
V. Meininger & E. Hirsch. (2006) Aspects éthiques des décisions de suppléance et leur réversibilité. Revue Neurologique 162, pages 329-333.
Crossref
Crossref